• 首页期刊简介编委会刊物订阅专栏专刊电子刊广告合作联系我们English
引用本文:付金芳,高青,胡瑞瑞,李宏伟,陈晓峰,郝海军.蒙花苷磷脂复合物的制备及其药动学评价[J].中国现代应用药学,2019,36(16):2039-2043.
FU Jinfang,GAO Qing,HU Ruirui,LI Hongwei,CHEN Xiaofeng,HAO Haijun.Buddleoside-phospholipids Complex: Preparation and Pharmacokinetic Evaluation[J].Chin J Mod Appl Pharm(中国现代应用药学),2019,36(16):2039-2043.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1603次   下载 774 本文二维码信息
码上扫一扫!
分享到: 微信 更多
蒙花苷磷脂复合物的制备及其药动学评价
付金芳1, 高青1, 胡瑞瑞1, 李宏伟2, 陈晓峰3, 郝海军3
1.郑州澍青医学高等专科学校, 郑州 450064;2.黄河科技学院, 郑州 450005;3.上海雷允上药业有限公司技术中心, 上海 201401
摘要:
目的 制备蒙花苷磷脂复合物,研究其药动学性质。方法 溶剂挥发法制备蒙花苷磷脂复合物,以复合率为评价指标,通过正交试验优化制备工艺。SD大鼠灌胃给予蒙花苷磷脂复合物,HPLC测定蒙花苷的血药浓度。结果 采用优化后的磷脂复合物制备工艺,复合率接近100%。X射线衍射结果表明蒙花苷以无定型状态存在于磷脂复合物中,在水和正辛醇中的表观溶解度显著增大。药动学结果显示,蒙花苷磷脂复合物的tmaxCmax,AUC0-t等参数与蒙花苷原料药相比具有显著性差异,口服吸收生物利用度提高1.11倍。结论 磷脂复合物改善了蒙花苷的溶解性质,口服吸收生物利用度得到明显提高。
关键词:  蒙花苷  磷脂复合物  生物利用度
DOI:10.13748/j.cnki.issn1007-7693.2019.16.011
分类号:R283.6
基金项目:"重大新药创制"国家科技重大专项(2018ZX09201009-002-009)
Buddleoside-phospholipids Complex: Preparation and Pharmacokinetic Evaluation
FU Jinfang1, GAO Qing1, HU Ruirui1, LI Hongwei2, CHEN Xiaofeng3, HAO Haijun3
1.Zhengzhou Shuqing Medical College, Zhengzhou 450064, China;2.Huanghe Science and Technology College, Zhengzhou 450005, China;3.Shanghai LeiYunShang Pharmaceutical Co., Ltd., Technique Center, Shanghai 201401, China
Abstract:
OBJECTIVE To prepare buddleoside-phospholipids complex, and then investigate its pharmacokinetic properties. METHODS The buddleoside-phospholipids complex was prepared by solvent evaporation method, and the compounding rate was used as the evaluation index. The preparation process was optimized by orthogonal experiment. After SD rats were administrated with drugs, the blood concentration of buddleoside was detected by HPLC. RESULTS The recombination ratio of buddleoside-phospholipids complex was near to 100% under the optimized preparations. The results of X-ray diffraction indicated that buddleoside showed an amorphous state in the complex. The solubility in water and octanol was enhanced greatly. Pharmacokinetic results in SD rats showed that the tmax, Cmax, AUC0-t and other parameters of the complex has significant difference compared to buddleoside suspension. The bioavailability of buddleoside was enhanced to 1.11 times by the complex. CONCLUSION The phospholipids complex improved the solubility property of buddleoside, and the oral bioavailability of buddleoside was improved significantly.
Key words:  buddleoside  phospholipids complex  bioavailability
扫一扫关注本刊微信